Find a Doctor
 
FJÁRFESTAR
FDA approved

FJÁRFESTAR


01: Press Releases

02: Management Team

Katherine D. Crothall, Ph.D

Forstjóri, framkvæmdastjóri og stjórnarformaður

Kathy hóf störf hjá Aspire sem forstjóri, framkvæmdastjóri og stjórnarformaður í nóvember 2010. Áður starfaði hún hjá Liberty Venture Partners, fjárfestingasjóði í Philadelphia á árunum 2006-2010. Þar áður starfaði hún hjá Animas Corporation (NASDAQ: PUMP; West Chester, PA) sem stofnandi, forstjóri og framkvæmdastjóri. Það fyrirtæki var leiðandi í framleiðslu insúlíndælna frá stofnun og þar til það var keypt upp af Johnson & Johnson (J&J) Corporation (NYSE: JNJ) í febrúar 2006. Enn fyrr tók Kathy jafnframt þátt í stofnun tveggja annarra fyrirtækja á sviði tækningatækja; Luxar Corporation (Seattle, WA) sem stofnað var 1988 og síðar selt til ESC Medical (NASDAQ: ESCMF) og Laakmann Electro-Optics, stofnað árið 1978 og selt til Johnson & Johnson árið 1981. Kathy stýrði Lakkmann Electro-Optics í fimm ár eftir yfirtöku.

Kathy er með BS gráðu frá University of Pennsylvania og doktorsgráðu frá University of Southern California í rafmagnsverkfræði. Hún á yfir 20 einkaleyfi og hefur fengið ýmsar viðurkenningar, þar á meðal Ernst & Young Entrepreneur of the Year Award árið 2003 og the Greater Philadelphia Raymond Rafferty Entrepreneurial Excellence Award árið 2004. Kathy er stjórnarforseti hjá Adhezion BioMedical og Xanitos, Inc. Hún er jafnframt verndari hjá School of Engineering and Applied Sciences við University of Pennsylvania.

Ryan Lake

Yfirmaður fjármála og fjármálastjóri

Ryan joined Aspire as Vice President of Finance and Chief Financial Officer (CFO) in July 2015. Prior to joining Aspire, Ryan held executive management and senior finance positions, including Director of the Natural Materials Division, Controller and Senior Director of Finance, at DSM Biomedical, a division of Royal DSM, a global science-based company active in health, nutrition and materials, since 2012. From 2002 to 2012, Ryan held various senior financial positions, most notably Senior Director of Finance and Interim CFO, with Kensey Nash Corporation, a publicly traded medical device company. From 1999 until 2002, Ryan was an Accounting and Audit Senior at the public accounting firm Deloitte & Touche, LLP. Prior to that, Ryan was an accountant at the forensic accounting firm Nihill & Riedley, P.C. Ryan is a Certified Public Accountant, Chartered Global Management Accountant and holds a B.S. degree in Accounting from West Chester University of Pennsylvania.

03: Board of Directors

  • Katherine D. Crothall, Ph.D

    Forstjóri, framkvæmdastjóri og stjórnarformaður

    Read Biography »

04: About Aspire

Aspire Bariatrics, Inc. is a privately-held company founded in 2005, based in the greater Philadelphia area. The initial product concept was developed as a collaboration between three physicians to provide an effective, low-risk method of weight loss for obese people. The three physicians, Dr. Sam Klein (Washington University in St. Louis), Dr. Moshe Shike (Memorial Sloan Kettering Cancer Center in New York), and Dr. Steve Solomon (Memorial Sloan Kettering), combining expertise in obesity, nutrition, gastroenterology, medical device discovery, and PEG (percutaneous endoscopic gastrostomy) tubes, modified a PEG tube to make it suitable for weight loss purposes. PEG tubes, used for long-term feeding of patients that cannot take in food orally, have been used for 30 years and have an established record of safety.  Their first patient with the modified tube lost 100% of her excess weight in 2005, and maintained her weight-loss for over five years post-procedure. Katherine Crothall, Ph.D., Aspire’s President and CEO, joined the Company in November 2010.